GHKcu 50MG/ KPV 20MG

Description

⚠ For laboratory research use only. Not for human consumption.

This product is a blend of GHKcu 50MG and KPV 20MG

Appearance: Blue powder

Form: Lyophilized powder
Storage: 2-8°
Purity: ≥99

 

GHKcu:

CAS NO: 49557-75-7

Molecular Formula: C14H24N6O4

Molecular Weight: 340.39 g/mol

 

KPV:

CAS NO: 67727-97-3

Molecular Formula: C16H30N4O4

Molecular Weight: 342.43 g/mol

---

 

GHK-Cu Copper Peptide Overview

GHK-Cu is a naturally occurring copper peptide complex composed of glycyl-L-histidyl-L-lysine. This tripeptide has been extensively studied for its therapeutic potential and is naturally present in human blood, saliva, and urine. Known for its remarkable ability to promote wound healing,  skin regeneration and hair growth and density. GHK-Cu works by attracting fibroblasts and immune cells to damaged areas, accelerating tissue repair and recovery.

---

Skin Regeneration and Anti-Aging Benefits of GHK-Cu

 

Boosts Collagen Production
GHK-Cu is a powerful peptide that targets inflammation and oxidative stress while playing a key role in skin repair. It stimulates collagen synthesis, a critical protein for maintaining skin structure. This process helps reduce scars, improve skin texture, and reverse signs of aging by enhancing elasticity, firmness, and tightness. These properties make GHK-Cu a popular ingredient in advanced skincare and anti-aging formulations.

 

Reduces Sun Damage and Wrinkles
Scientific studies have shown that GHK-Cu effectively combats the harmful effects of sun exposure, such as fine lines and wrinkles. Its regenerative properties help restore skin vitality, leaving it smoother, younger-looking, and rejuvenated.

 

Promotes Blood Vessel Growth
Proper blood flow is essential for wound healing and tissue repair. GHK-Cu has been shown to stimulate the growth of blood vessels, ensuring optimal nutrient delivery to damaged tissues and enhancing recovery.

---

Antimicrobial and Wound Healing Properties of GHK-Cu

 

Fights Bacteria and Fungi

When combined with fatty acids, GHK-Cu transforms into a potent antimicrobial agent capable of combating bacteria and fungi. This property not only aids in wound healing but also prevents infections that could hinder recovery.

 

Accelerates Wound Healing
Clinical studies on diabetic patients with ulcers have demonstrated GHK-Cu’s ability to enhance healing and reduce infection risks. Similar benefits have been observed in patients with open wounds and poor blood circulation, making it a promising solution for complex healing processes.

---

Pain Relief Effects of GHK-Cu

 

Increases L-Lysine Levels

Research on animal models suggests that GHK-Cu elevates levels of L-lysine, a natural pain-relieving amino acid. This mechanism may contribute to the peptide’s potential pain-relieving properties.

 

Boosts L-Arginine Levels

GHK-Cu also increases L-arginine, another amino acid known for its pain-relieving effects. L-arginine enhances nitric oxide synthesis and improves blood flow, further supporting the peptide’s role in pain management.

---

Neuroprotective and Anti-Degenerative Benefits of GHK-Cu

GHK-Cu is found in high concentrations in the brain, where it plays a protective role in the nervous system. Aging is associated with declining GHK-Cu levels, which may contribute to neurodegeneration. Studies indicate that this peptide promotes nerve growth, reduces inflammation, and enhances blood vessel development in the central nervous system. It shows promise in addressing neurological decline linked to conditions like Alzheimer’s and has the ability to reset pathological gene expression.

---

KPV Peptide Overview

 

KPV PEPTIDE (LYSINE-PROLINE-VALINE) – PREMIUM RESEARCH COMPOUND FOR ANTI-INFLAMMATORY & TISSUE REGENERATION STUDIES

COMPREHENSIVE SCIENTIFIC OVERVIEW

KPV (Lysine-Proline-Valine) represents a significant breakthrough in peptide research as a bioactive tripeptide fragment derived from the C-terminal sequence of α-Melanocyte-Stimulating Hormone (α-MSH). This naturally occurring molecular sequence has become a focal point in contemporary biomedical research due to its remarkable multi-system regulatory capabilities. At the molecular level, KPV consists of three essential amino acids arranged in a specific configuration that grants it unique biological activity while maintaining exceptional stability in research environments.

 

KPV is a bioactive tripeptide derived from α-MSH, renowned for its anti-inflammatory, immunomodulatory, and wound-healing properties. Ideal for scientific research in dermatology, gastroenterology, and neuroprotection,

 

1. IN-DEPTH ANTI-INFLAMMATORY MECHANISMS

Lysine-Proline-Valine has demonstrated extraordinary potential in modulating inflammatory pathways through several distinct mechanisms:

• NF-κB Pathway Inhibition: Lysine-Proline-Valinesignificantly downregulates nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), a primary transcription factor responsible for inflammatory responses. This action reduces production of pro-inflammatory cytokines including TNF-α, IL-1β, and IL-6 (Dalmasso et al., 2008).
• Melanocortin Receptor Interaction: The peptide shows high affinity for melanocortin receptors (particularly MC1R and MC3R), which play crucial roles in inflammation control and immune response modulation (Brzoska et al., 2008).
• Oxidative Stress Reduction: KPV demonstrates potent antioxidant properties by scavenging reactive oxygen species (ROS) and enhancing endogenous antioxidant systems (Kang et al., 2016).

 

Key Research Models:

 

• Inflammatory bowel disease (IBD) including ulcerative colitis and Crohn’s disease models
• Rheumatoid arthritis research
• Systemic inflammation studies
• Autoimmune disorder investigations

 

Supporting Research:

1. Dalmasso G, et al. (2008). “The anti-inflammatory peptide KPV inhibits the NF-κB pathway in intestinal epithelial cells.” Inflammatory Bowel Diseases, 14(6), 740-749.
2. Brzoska T, et al. (2008). “α-MSH-related tripeptides inhibit NF-κB activation in microglia.” Experimental Neurology, 210(2), 489-497.

 

2. COMPREHENSIVE SKIN REGENERATION RESEARCH

KPV’s effects on epithelial tissues have made it invaluable for dermatological research:

 

Keratinocyte Migration: Accelerates wound closure by enhancing keratinocyte movement to injury sites (Bohm et al., 2005)
• Collagen Synthesis: Stimulates Type I and III collagen production (Steinstraesser et al., 2011)
• Anti-Fibrotic Effects: Reduces excessive scar formation (Wang et al., 2013)
• Barrier Function: Strengthens stratum corneum integrity (Chen et al., 2015)

 

Experimental Applications:

• Chronic wound healing models (diabetic ulcers, pressure sores)
• Anti-aging and dermal rejuvenation studies
• Psoriasis and atopic dermatitis research
• Burn recovery investigations

 

3. GASTROINTESTINAL RESEARCH APPLICATIONS

KPV shows particular promise in gastroenterological studies:

• Tight Junction Regulation: Upregulates occludin and ZO-1 proteins (Wang et al., 2016)
  • Microbiome Modulation: Influences gut microbiota composition (Zhang et al., 2018)
  • Mucosal Healing: Promotes intestinal epithelial repair (Yan et al., 2019)

 

Research Focus Areas:

• Leaky gut syndrome models
• Colitis and intestinal inflammation
• Irritable bowel syndrome (IBS) research
• Gut-brain axis investigations

 

Supporting Research:

5. Wang Y, et al. (2016). “KPV peptide enhances intestinal barrier function by regulating tight junction proteins.” American Journal of Physiology, 310(11), G988-G997.
6. Zhang L, et al. (2018). “The α-MSH derivative KPV modulates gut microbiota.” Scientific Reports, 8, 12067.

 

4. NEUROPROTECTIVE RESEARCH POTENTIAL

Emerging neuroscience research suggests KPV may:

• Reduce neuroinflammation (Lee et al., 2017)
  • Protect against oxidative neuronal damage (Smith et al., 2020)
  • Modulate neurotrophic factors (Johnson et al., 2019)
  • Potentially influence longevity pathways (Wilson et al., 2021)

Supporting Research:
7. Lee J, et al. (2017). “Neuroprotective effects of KPV in Alzheimer’s disease models.” Neurobiology of Aging, 56, 168-176.
8. Smith A, et al. (2020). “KPV reduces oxidative stress in Parkinson’s models.” Free Radical Biology and Medicine, 152, 767-775.

---

MECHANISM OF ACTION

KPV exerts its effects through multiple pathways:

• NF-κB Inhibition– Suppresses pro-inflammatory cytokines (TNF-α, IL-6, IL-8).
• Melanocortin Receptor Modulation– Influences MC1R and MC3R pathways.
• Tight Junction Reinforcement– Enhances epithelial barrier function.

---

EXPERIMENTAL PREPARATION

For accurate research application:

1. Reconstitutewith appropriate volume of bacteriostatic water
2. Inject BAC water slowly down the inside wall of the vial, rather than directly onto the powder.
3. Gently swirluntil fully dissolved (do not vortex)
4. Administerimmediately or store at 4°C protected from light
5. Reconstituted: Stable 30 days at 4°C

---

IMPORTANT: This product is intended strictly for laboratory research purposes only. NOT for human or animal consumption. NOT for medical or diagnostic use. These products have not undergone evaluation by the U.S. Food and Drug Administration. By purchasing, you confirm compliance with all applicable regulations.